Chile Welcomes Generic Ozempic: A New Era for Obesity and Diabetes Treatment
The arrival of generic versions of Ozempic in Chile, most notably “Selfix,” is reshaping access to treatments for obesity and type 2 diabetes. This shift is driven by lower costs and increased availability, offering a potential lifeline to millions. Although, experts emphasize the critical need for medical supervision and informed usage.
Selfix: What You Need to Know
Selfix, the first Chilean-made generic semaglutide, is expected to launch in the first half of 2026, pending final approval from the Public Health Institute (ISP). It will be available in the same three dosages as the original Ozempic – 0.1mg, 0.5mg, and 1mg – in injectable form. The key benefit is a “significantly” lower price point compared to the branded medication, addressing a major barrier to access in Chile, where Ozempic can cost over $200,000 pesos monthly.
The Rise of Semaglutide and the Need for Affordable Options
Semaglutide, the active ingredient in both Ozempic and Wegovy, has proven effective in weight loss and improving health indicators. However, its high cost has limited access, particularly in countries like Chile. Obesity rates in Chile have increased by 204% in the last decade, far outpacing the rise in the United States, according to the Organisation for Economic Co-operation and Development (OECD). This increase is linked to numerous health complications, including type 2 diabetes, hypertension, and various cancers.
Expert Warnings: Responsible Use is Paramount
Nutritional specialist Javiera Salvador cautions against viewing these medications as quick fixes. She stresses that they require thorough medical evaluation, examinations, and ongoing professional monitoring. The importance of bioequivalence in generic medications is too highlighted, ensuring they deliver the same effects and safety as the original drug. Potential side effects, such as nausea, are more likely with misuse or unsupervised consumption.
Bioequivalence and Quality Control
Generic medications must meet strict bioequivalence standards to guarantee they have the same therapeutic effect as the brand-name drug. Semaglutide’s action is directly related to blood sugar regulation and appetite control, making consistent formulation crucial. Experts warn against purchasing products from informal markets, as they may not meet necessary health standards.
Beyond Cost: A Holistic Approach to Treatment
While the arrival of Selfix offers a more affordable option, experts agree that the focus should remain on responsible use, coupled with lifestyle changes and medical follow-up. These medications are best viewed as a tool within a comprehensive treatment plan, rather than a standalone solution.
Key Questions About Ozempic and Selfix
- What’s the difference between Ozempic and its generic version like Selfix? The primary difference is cost, and brand. Both contain semaglutide, but generics must demonstrate bioequivalence to ensure the same safety and effectiveness.
- Who can use these medications for weight loss? They are not for everyone seeking minor weight loss. They are intended for patients with obesity, significant overweight, or associated conditions like diabetes or insulin resistance, and require medical evaluation.
- What are the main risks or side effects? Common side effects include nausea and gastrointestinal discomfort. These risks increase with misuse or unsupervised use.
Pro Tip: Always consult with a healthcare professional before starting any new medication, including generic versions of Ozempic. Discuss your medical history, potential risks, and appropriate dosage.
Did you know? The patent for semaglutide has also expired in other countries, leading to the availability of more affordable generic options globally, including in India.
Explore further resources on semaglutide and diabetes management at WebMD and Medscape.
Have questions about Selfix or Ozempic? Share your thoughts in the comments below!
Related reading